Abstract
Backgrounds: High-altitude pulmonary edema (HAPE) is a life-threatening disease without effective drugs. Caffeine is a small molecule compound with antioxidant biological activity used to treat respiratory distress syndrome. However, it is unclear whether caffeine plays a role in alleviating HAPE.
Methods: We combined a series of biological experiments and label-free quantitative proteomics analysis to detect the effect of caffeine on treating HAPE and explore its mechanism in vivo and in vitro.
Results: Dry and wet weight ratio and HE staining of pulmonary tissues showed that the HAPE model was constructed successfully, and caffeine relieved pulmonary edema. The proteomic results of mice lungs indicated that regulating mitochondria might be the mechanism by which caffeine reduced HAPE. We found that caffeine blocked the reduction of ATP production and oxygen consumption rate, decreased ROS accumulation, and stabilized mitochondrial membrane potential to protect AT1 cells from oxidative stress damage under hypoxia. Caffeine promoted the PINK1/parkin-dependent mitophagy and enhanced mitochondrial fission to maintain the mitochondria quality control process.
Conclusion: Low-dose of caffeine alleviated HAPE by promoting PINK1/parkin-dependent mitophagy and mitochondrial fission to control the mitochondria quality. Therefore, caffeine could be a potential treatment for HAPE.
Highlights
• Caffeine alleviated high altitude pulmonary edema in vivo.
• Caffeine reduced oxidative stress and stabilized mitochondrial morphology in AT1 cells under hypoxia.
• Caffeine alleviated HAPE by regulating the PINK1/Parkin-mediated mitophagy, mitochondrial fission, and mitochondrial biogenesis to maintain the quality control of mitochondria.
1 Introduction
Acute high altitude illness (AHAI) frequently occurs when a person ascends to a high altitude of more than 2500 m (m), which is hypoxic, hypobaric, and ultraviolet intensive (Khodaee et al., 2016). The incidence of AHAI is approximately 50%–85% for unacclimatized individuals at 4500–5500 m (Hackett et al., 1976). High altitude pulmonary edema (HAPE) is a severe subtype of AHAI, which is characterized by pulmonary edema, dyspnea, lung moist rales, cyanosis, dry cough with exertion, and pink frothy sputum (Swenson and Bartsch, 2021). The mortality rate of individuals with untreated HAPE is approximately 50% (Yanamandra et al., 2019). The typical pathogenesis of HAPE is pulmonary edema caused by excessive pulmonary vasoconstriction and abnormally high pulmonary pressures (Sharma Kandel et al., 2020). In the guidelines for prevention and treatment of acute altitude illness, acetazolamide, nifedipine, sildenafil, salmeterol, and dexamethasone are drugs used for the prevention of HAPE; acetazolamide, a diuretic, and dexamethasone are drugs used for the treatment of HAPE. However, the effectiveness of these therapies was unsatisfactory (Luks et al., 2019; Luks and Hackett, 2022). The plateau environment is a natural hypoxic environment. Hypoxia induces reactive oxygen species (ROS) accumulation and leads to oxidative stress damage in multiple diseases, such as inflammation (McGarry et al., 2018), cardiovascular disease (Giussani et al., 2014), and lung damage (Tuleta et al., 2016). Hence, inhibiting oxidative stress damage has the potential to protect the lungs from damage, holding the promise of treating HAPE.
Caffeine is a natural methylxanthine occurring in several beverages, such as coffee, tea, and cola, which is often used to fight fatigue and boost energy levels (Szlapinski et al., 2023). Caffeine has both pro-oxidative stress and anti-oxidative stress properties depending upon the dosage. Min et al. reported that intake of 10 mM caffeine causes mitochondrial dysfunction and increases oxidative stress by decreasing the level of phosphoethanolamine (PE) (Min et al., 2020). While several studies reviewed that a low dose of caffeine (10 μM) can protect several tissues from hypoxic damage by inhibiting oxidative stress damage (Ikram et al., 2020; Marte et al., 2020; Barrea et al., 2021). Such as, reducing renal fibrosis (Nilnumkhum et al., 2019), promoting neonatal neuronal survival (Li et al., 2019), and alleviating ultraviolet-induced skin senescence (Li et al., 2018).
Recent studies have revealed that caffeine is widely used to treat respiratory distress syndrome (RDS) in premature infants and improve the prognosis (Ren et al., 2015; Ines et al., 2021; Elmowafi et al., 2022). The leading cause of RDS is increased pulmonary capillary permeability caused by inflammation and endothelial dysfunction (Millar et al., 2016). The antioxidant is essential in protecting human pulmonary artery endothelial cells against excessive permeability, alleviating acute RDS (Li et al., 2020). HAPE has similar symptoms and pathological changes as RDS. However, there are no reports on whether caffeine plays a role in alleviating HAPE.
In this study, we found that a low dose of caffeine neutralized oxidative stress damage in AT1 cells by upregulating the expression of multiple genes involved in mitochondrial dynamics and mitophagy under hypoxic conditions. Caffeine promoted the PINK1/parkin-dependent mitophagy and mitochondrial fission to control the mitochondria quality both in vivo and in vitro. Moreover, we also found that pulmonary congestion and alveolar structural destruction caused by hypoxia were alleviated by caffeine in the lungs. Collectively, our results indicated that caffeine could be a potential treatment for HAPE.
2 Materials and methods
2.1 Animal care
Eight-week-old male C57BL/6 mice were purchased from SPF (Beijing) Biotechnology (Beijing, China). Animals were fed under conditions of constant humidity (50% ± 5%), temperature (23°C ± 2°C), and illumination (12 h light/dark cycles). All animal experiments were conducted following the National Institutes of Health’s Guide for the Care and Use of Laboratory Animals (NIH publication No. 80–23, revised in 1996). The Animal Ethics Committee of the Chinese PLA General Hospital (SQ2020030) approved all experimental procedures involving animals.
2.2 Mice and caffeine treatment
Mice were divided into three groups randomly (n = 6 in each) which received: (1) Control group (Con); (2) Mice were exposed to hypobaric hypoxic conditions for 3 days (Hypoxia group, Hypo); To construct the mice models of high altitude pulmonary edema, we exposed mice to a hypobaric hypoxic chamber for 3 days, which referred to our previous studies and reported methods (Ni et al., 2014; Tian et al., 2021). (3) Mice were exposed to hypobaric hypoxic conditions 3 days, and given caffeine intervention by oral gavage caffeinated water (Velazquez et al., 2020; Szlapinski et al., 2023) (Caffeine from Sigma–Aldrich, St. Louis, MO, U.S., 0.2 g/kg/d, dose volume of 10 mL/kg/d body weight) (Hypoxia + caffeine group, Hypo + Caf). The human equivalent dose based on body surface area (Km value for humans = 37 and for mice weighing 25 g = 3) was 2.5 mg/kg/day (Nair and Jacob, 2016), which was approximately 1-2 cups of canned coffee or specialty espresso (McGuire, 2014). The hypobaric hypoxic environment was constructed to simulate a 5,500-m-high atmospheric environment using a FLYDWC50-1C hypobaric hypoxic cabin (Guizhou Fenglei Air Ordnance LTD., Guizhou, China).
2.3 HE staining
The lung specimens were fixed in 4% paraformaldehyde overnight, embedded in paraffin, and sectioned into 6 μm thick slices. Tissue sections were stained with hematoxylin for 5 min and eosin for 3 min. HE-stained sections were analyzed using an optical microscope (Nikon, Japan).
2.4 Dry and wet weight ratio of lung
The pulmonary dry and wet weight ratio reveals the severity of pulmonary edema. To calculate the dry/wet ratio, we weighed the whole left lung at the initial removal and after drying it in an oven at a temperature of 160°C for 72 h.
2.5 LC-MS analysis
Liquid chromatography-tandem mass spectrometry (LC-MS) was carried out as described previously (Goldman et al., 2019). Briefly, cells or lungs were sonicated three times on ice using a high-intensity ultrasonic processor (Scientz, China) in the lysis buffer. Then the proteins were digested by trypsin. The peptides were subjected to NSI source followed by tandem mass spectrometry (MS) in Q Exactive TM Plus (ThermoFisher Scientific, U.S.) coupled online to the ultra-performance liquid chromatography (UPLC). The proteomic experiments of lungs were finished by the ptm-biolab (Hangzhou, China). The proteomic experiments of AT1 cells were completed by Metware Biotechnology Co. (Wuhan, China). The resulting LC-MS data were processed using the Maxquant search engine (v.1.5.2.8). The minimum score for modified peptides was set at> 40, and FDR was <1%. The LFQ (label-free quantitation) intensity was mean-based scaled per protein in all the samples, which was used in the downstream analysis.
2.6 Differential expression analysis
The analysis of differentially expressed proteins (DEPs) was implemented through the Limma package in the R language. The DEPs are defined as |logFC|>1.5 and p-value < 0.05. Proteins with logFC >1.5 are defined as upregulated proteins. Proteins with LogFC < −1.5 are defined as downregulated proteins.
2.7 GO annotation
Gene Ontology (GO) is a major bioinformatics initiative to unify the representation of genes and gene product attributes across all species (Ashburner et al., 2000). Gene Ontology (GO) annotation proteome was derived from the UniProt-GOA database (http://www.ebi.ac.uk/GOA/). Proteins were classified by Gene Ontology annotation based on three categories: biological process, cellular component, and molecular function.
2.8 KEGG pathway annotation
The Kyoto Encyclopedia of Genes and Genomes (KEGG) database were used to annotate protein pathways (Kanehisa et al., 2021). Firstly, using KEGG online service tool KAAS to annotate the protein’s KEGG database description and then mapping the annotation result on the KEGG pathway database using KEGG online service tool KEGG mapper.
2.9 Enrichment of pathway analysis
The KEGG database was used to identify enriched pathways by a two-tailed Fisher’s exact test to test the enrichment of the DEPs against all identified proteins. The pathway with a p-value <0.05 was considered significant.
2.10 Protein-protein interaction network
All DEPs were searched against the STRING database version 11.5 for protein-protein interactions (Szklarczyk et al., 2021). We fetched all interactions that had a confidence score ≥0.7 (high confidence) and visualized the interaction network using Cytoscape String App (Doncheva et al., 2019). The significant modules with a score ≥5 were screened out via MCODE.
2.11 The construction of the cell model
Type Ⅰ alveolar epithelial (AT1) cells were purchased from Beijing Qianzhao Xinye Biology Science and Technology Company (Beijing, China). Cells were cultured in DMEM with 10% Fetal bovine serum (FBS) and 1% antibiotics (Penicillin and Streptomycin). The hypoxic model cells were constructed by exposure to 1% O2 for 24 h, according to the pathological hypoxic cell model construction (McKeown, 2014).
2.12 Cell activity measurements
AT1 cells were seeded in the 96-well plate at 8000 cells/100 ul/well. The CCK-8 solution (Cell Counting Kit-8, Coolaber, Beijing) was added to each well according to the manufacturer’s instructions. Plates were incubated at 37°C and measured the absorbance at 450 nm using a microplate reader (BioTek, U.S.). The concentration of 0 μM, 5 μM, 10 μM, 15 μM, 20 μM, 40 μM, and 80 μM caffeine were co-cultured with cells, and the optimum concentration was calculated.
2.13 Mitochondrial real-time ATP rate assay
AT1 cells were inoculated in a 24-well cell culture plate and incubated at 37°C with 5% CO2 overnight. The following compounds were injected into the cell culture medium: oligomycin (1.5 μM), a mixture of rotenone (0.5 μM) and antimycin A (0.5 μM). The oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were measured by Seahorse XFe/XF24 Analyzers (Agilent Technologies, U.S.) according to instructions.
2.14 Mitochondrial Mito Stress Test kit assay
AT1 Cells were inoculated in a 24-well cell culture plate and incubated at 37°C with 5% CO2 overnight. The following compounds were injected into the cell culture medium: oligomycin (1.0 μM), FCCP (1.0 μM), and a mix of rotenone and antimycin A (0.5 μM)) to measure ATP production, maximal respiration, and non-mitochondrial respiration, respectively.
2.15 Mitochondrial glycolysis rate assay
AT1 Cells were inoculated in a 24-well cell culture plate and incubated at 37°C with 5% CO2 overnight. The following compounds were injected into the cell culture medium: a mixture of rotenone (0.5 μM) and antimycin A (0.5 μM), and 2-deoxy-D-glucose (2-DG, 500 mM). The proton efflux rate (PER) and glycolytic rate were measured by Seahorse XFe/XF24 Analyzers (Agilent Technologies, U.S.) according to instructions.
2.16 Determination of reactive oxygen species (ROS) in the cytoplasm and mitochondria
The CellROX™ Deep Red reagent is a novel fluorogenic probe for measuring cellular oxidative stress which is to be fluorescent upon oxidation by reactive oxygen species. The cytoplasmic ROS was measured using CellROX® Deep Red Reagent according to the manufacturer’s instructions (CellROX® Oxidative Stress Reagents (C10422), ThermoFisher Scientific, U.S.). To detect the mitochondrial superoxide, we used the MitoSOX which could selectively detect the superoxide in the mitochondria of live cells (Kalyanaraman et al., 2012; Forman et al., 2015) (MitoSOX™ Red mitochondrial superoxide indicator (M36008), ThermoFisher Scientific, U.S.). Briefly, cells were incubated with the CellROX®/MitoSOX Reagent at a final concentration of 5/10 μM for 30 min at 37°C, then removed medium and washed cells three times with PBS. The cells were supplemented with an antifade mounting medium with DAPI. Images were acquired using the OLYMPUS FV1000 inverted confocal microscope (Japan).
2.17 Determination of mitochondrial membrane potential
The mitochondrial membrane potential (MMP) was measured using JC-1 (5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide), which exhibits potential-dependent accumulation in mitochondria according to the manufacture instruction (MitoProbe™ JC-1 Assay Kit (M34152), ThermoFisher Scientific, U.S.). The JC-1 dye loading solution was diluted into a final concentration of 2 μM. Then, the cells were co-incubated with JC-1 dye at 37°C with 5% CO2 for 30 min. Then the medium was removed and cells were washed three times with PBS. The cells were supplemented with an antifade mounting medium with DAPI. Images were acquired using the OLYMPUS FV1000 inverted confocal microscope (Japan).
2.18 Immunofluorescence
For confocal immunofluorescence analysis, cells were fixed in 4% formaldehyde for 10 min, then permeated in 0.2% Triton X-100 for 5 min and blocked in 3% BSA for 2 h. The incubation condition was as follows: CoraLite®488-conjugated TOM20 Monoclonal antibody (CL488-66777, Proteintech, China, 1:200 dilution), CoraLite®594-conjugated LAMP1 Monoclonal antibody (CL594-67300, Proteintech, China, 1:200 dilution), MTCO2 Mouse Monoclonal Antibody (A-6404, ThermoFisher Scientific, U.S., 1:200 dilution) and Parkin Polyclonal Antibody (PA5-13399, ThermoFisher Scientific, U.S., 1:50 dilution) at 4°C over-night. After being washed three times with TBST, the cells were co-incubated with/without fluor-conjugated goat anti-rabbit secondary antibody (red) (SA00013-4, Proteintech, China, 1:200 dilution) and fluor-conjugated goat anti-mouse secondary antibody (green) (SA00013-1, Proteintech, China, 1:200 dilution). The cells were supplemented with an antifade mounting medium with DAPI. Images were acquired using the OLYMPUS FV1000 inverted confocal microscope (Japan). Mitophagy was measured by the co-expression fluorescence of yellow dots (LAMP1 and Tom20 overlay) per field.
2.19 Transmission electron microscopy
The freshly harvested cells were processed as described previously (Labuschagne et al., 2019). The sections with a thickness of 70 nm were observed under an HT7800 transmission electron microscope (Hitachi, HT7800).
2.20 Isolation of mitochondria
Mitochondria were isolated by a mitochondrial isolation kit (Mitochondrial extraction Kit (SM0020), Beijing Solarbio Science & Technology Company, China). Briefly, the AT1 cells were washed three times with PBS and collected after centrifugation at 800 g for 10 min 500 μL lysis buffer was added to resuspend the cells. Then the cells were ground 30–40 times in a 0°C ice bath in a small-capacity glass homogenizer. Cell debris and nuclei were removed by centrifugation at 1000 g for 5 min, 4°C. And mitochondrial fractions were collected by centrifugation at 12,000 g for 15 min, 4°C.
2.21 Quantitative real-time PCR
AT1 cells were collected and washed 3 times with PBS. Trizol reagents were added to dissociate nucleoproteins (TRIzol™ (15596026), ThermoFisher Scientific, U.S.). Total RNA was extracted following the manufacturer’s protocol. Then the total RNA was reversed into cDNA (GoTaq® qPCR Master Mix (A6001), Promega, U.S.). Quantitative RT-PCR analysis was actualized by Bio-Rad CFX96 Real-Time PCR Detection System (Bio-Rad, U.S.). The sequences of primers used in this study are listed in Supplementary Table S3.
2.22 Western blotting
The protein lysates were prepared in RIPA buffer and phenylmethylsulfonyl fluoride (Merck Millipore, U.S.). The concentration of protein was measured by the BCA assay (NO.23225, ThermoFisher Scientific, U.S.). The quality of 20 μg proteins was loaded per condition. Proteins were separated by 4%–20% SDS-polyacrylamide gel electrophoresis and then transferred to nitrocellulose membranes. The membranes were incubated in 5% milk for 2 h before incubation with primary antibodies at 4°C overnight. Primary antibodies were as follows: Platelet-type phosphofructokinase (PFKP, 8164, 1:1000 dilution), Pyruvate kinasem1/2 (PKM1/2, 3106, 1:1000 dilution), Tom20 (42406, 1:1000 dilution), LC3A/B (4108, 1:1000 dilution), PINK1(4946, 1:1000 dilution), Parkin (L211, 1:1000 dilution), Bnip3L (12396, 1:1000 dilution) and FUNDC1 (49240, 1:1000 dilution) were purchased from Cell Signaling Technology (U.S.). DRP1 (ab56788, 1:1000 dilution) and Hexokinase II (ab209847, 1:1000 dilution), ACTIN (ab6276, 1:1000 dilution) were purchased from Abcam (U.S.). Glucose-6-phosphate isomerase protein (GPI, PA5-97517) and P-Ser65-Parkin (Ser65) (p-Parkin, PA5-114616) were purchased from ThermoFisher Scientific (U.S.), Tim23 (67535-1-Ig, 1:4000 dilution), PGC1α (66369-1-Ig, 1:10000 dilution) were purchased from Proteintech (China). After being washed three times with TBST, the membranes were incubated with corresponding secondary antibodies (1:5000 dilution) and visualized using the instrument Amersham imager 600 (GE Healthcare Life Sciences, U.S.). The relative levels of individual proteins to control ACTB/VDAC were analyzed by ImageJ software (Madison, WI, U.S.).
2.23 Statistical analysis
Results were represented by means ± S.D. Statistical analyses were performed using GraphPad Prism 8.0 Software (GraphPad Software Inc., America). The choice of statistical tests for pairwise comparisons was made based on whether the data satisfies a normal distribution and/or equal variance tests. For normally distributed continuous variables, an independent sample t-test was used for statistical significance between two experimental groups. Otherwise, a Mann-Whitney U test was deployed. p-value (p) < 0.05 was considered statistically significant.
3 Results
3.1 Caffeine alleviates HAPE might by regulating mitochondrial OXPHOS
To examine the effect of caffeine on alleviating HAPE, we conducted multi-level biological assays and bioinformatic analysis in vivo and in vitro. The schematic overview of our experimental workflow was shown in Figure 1. We found that pulmonary congestion and alveolar structural destruction were severe after hypobaric hypoxia intervention, but caffeine attenuated these changes (Figure 2A). Compared with the control group, the dry and wet weight ratio (D/W weight ratio) significantly declined in the Hypo group (16% reduction, p = 0.0001, Figure 2B), suggesting severe pulmonary edema. Notably, caffeine neutralized the decrease in the dry and wet weight ratio (16% increase, p = 0.0004, Figure 2B) and relieved pulmonary edema. To explore the mechanism of caffeine in alleviating HAPE, we performed label-free quantitative proteomics for the mice lungs to search for crucial proteins. We detected 64,300 unique peptides from 3,105,702 MS spectra (Supplementary Figure S1A). Principal component analysis (PCA) with all the identified proteins could be separated between the Con group, Hypo group, and Hypo + Caf group (Figure 2C). The PCA results also validated that our model construction was successful. We found 327 DEPs between Hypo and Control groups and 93 DEPs between Hypo + Caf and Hypo groups (Supplementary Figure S1B; Supplementary Table S1). The heatmap with hierarchical clustering of DEPs between the Hypo + Caf group and the Hypo group showed a clear separation (Figure 2D). The subcellular location of these DEPs varied greatly, and mitochondria were the organelle with the greatest difference. 16% of upregulated DEPs in the Hypo group compared with the Con group were located in the mitochondria (Supplementary Figure S1C), and 17% of downregulated DEPs in the Hypo + Caf group compared with the Hypo group were located in the mitochondria (Figure 2E). Volcano plots with the labeled top 20 DEPs were shown (Figure 2F; Supplementary Figure S1D). Notably, we found multi-subunit genes of mitochondria, such as Ndufs1, Ndufa10, Ndufb8, and Atp6ap1 (Figure 2F). Gene Ontology (GO) enrichment analysis revealed that the downregulated DEPs between Hypo + Caf and Hypo groups were significantly enriched in cellular respiration, mitochondrial respiratory complexes and NADH dehydrogenase oxidative phosphorylation (Figure 2H; Supplementary Figure S1E–G). The enriched KEGG pathways of DEPs between the Hypo and Hypo + Caf groups showed that the most significantly downregulated pathway was oxidative phosphorylation (Figure 2G). In detail, hypoxia upregulated the expression of oxidative phosphorylation pathway-associated proteins, and caffeine maintained its normal levels (Figure 2H). The mRNA expressions of the mitochondrial oxidative phosphorylation genes were decreased by caffeine in hypoxia (Supplementary Figure S2B). Hence, we concluded that the mechanism of caffeine alleviating HAPE may be through the regulation of the mitochondrial oxidative phosphorylation pathway.
FIGURE 1
FIGURE 2
3.2 Effects of caffeine on mitochondrial ATP metabolism
Mitochondria are the powerhouses of animal cells. To explore the effects of caffeine on mitochondrial bioenergetics, we measured energy metabolism phenotypes using AT1 cells, which cover more than 95% of the internal surface of the lung (Eaton et al., 2009). One of the functions of AT1 cells is the reabsorption of excess lining fluid from the alveolar surface (Baloglu et al., 2020). The effect of cell viability was detected by the CCK8 assay. Hypoxia decreased cell viability, and caffeine increased cell viability in a dose-dependent manner. We found that caffeine at 10–20 μM significantly increased the cell viability of AT1 cells, and 15 μM caffeine was the optimum concentration (Supplementary Figure S2A).
The total ATP production was composed of mitochondrial oxidative phosphorylation-produced ATP (mitoATP) and glycolysis-produced ATP (glycoATP). The mitoATP and glycoATP were calculated by measuring the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), separately (Supplementary Figures S2C,D). The total ATP was decreased in hypoxia, but reversed by caffeine (Figure 3A). The mitoATP dramatically decreased in hypoxia, and caffeine mitigated the decrease in the Hypo + Caf group (Figure 3B). The glycoATP was significantly increased in hypoxia, and caffeine amplified this change (Figure 3C). Cell Mito Stress Test was detected to explore the mitochondrial activity (Figure 3D). Hypoxia decreased basal respiration, but caffeine did not affect it (Supplementary Figure S2E). The maximal and ATP production respiration decreased in hypoxia, and caffeine reversed these changes (Figures 3E,F). GlycoATP production is almost four times of mitoATP in hypoxia (Figure 3A). As a result, glycolysis becomes the primary source of ATP synthesis in hypoxic conditions. To determine the rate of glycolysis, we measured the glycolytic rate and maximum glycolytic capacity using Seahorse XF Glycolytic Rate Assay (Figure 3G). The basal glycolysis and the compensatory glycolysis were increased in hypoxia compared to the control, and caffeine further amplified the increase (Figures 3H,I). The expressions of rate-limiting enzymes in glycolysis were detected by Western blot (Figure 3J). Compared with normoxia, hypoxia increased the expression of HK2, GPI, PFKP, and PKM1/2, and caffeine amplified the increased degree of PFKP and PKM1/2 (Figures 3K–N). These findings suggest that caffeine increased the glycolytic capacity to supply energy in hypoxia.
FIGURE 3
3.3 Caffeine reduces mitochondrial damage triggered by hypoxia
To determine whether caffeine repaired the mitochondria damage caused by hypoxia, we detected the production of ROS and the changes in MMP. Previous studies have shown that damaged mitochondria will increase ROS production, decrease MMP and injure ATP synthesis (Labuschagne et al., 2019). We found that hypoxia significantly increased both the cytoplasmic ROS production and mitochondrial ROS production, but caffeine reduced the cytoplasmic and mitochondrial ROS accumulation (Figures 4A–D). MMP is a crucial parameter for evaluating mitochondrial function. MMP depolarization indicates cells become less healthy (Sakamuru et al., 2016). Oxidative stress damage caused the depolarization of MMP and further aggravated mitochondrial dysfunction. We found MMP got significantly depolarized in hypoxia, while caffeine maintained the normal MMP (Figures 4E,F). These results suggested that mitochondrial damage and oxidative stress triggered by hypoxia could be relieved by caffeine.
FIGURE 4
3.4 Caffeine reduces oxidative stress and stabilizes mitochondrial morphology
We found abnormally shaped mitochondria in the Hypo group compared to the typical conformation seen in the Con group in the transmission electron microscopy analysis (Figure 4G). Notably, mitochondria in the Hypo group showed more apparent cristae rarefication and swelling, wherein mitochondrial ultrastructure was severely disorganized. Caffeine normalized the damaged mitochondrial conformation in hypoxia (Figure 4G). While the number of mitochondria per high-power field showed no difference in each group (Figure 4H). We also found that Hypoxia increased the degradation of mitochondrial membrane proteins Tom20 and Tim23 (Figures 4I–K), reflecting the mitochondrial damage (Narendra et al., 2008). But caffeine attenuated the degradation (Figures 4I–K). These results indicated that caffeine protected the morphology and maintained the health of mitochondria.
3.5 Mechanism of the mitochondrial protective effects of caffeine
To investigate the mechanism of caffeine protective effects on mitochondria, we further implemented the label-free quantitative proteomics analysis in AT1 cells. We detected 104729 peptides and 7571 proteins (Supplementary Figure S3A). PCA showed that the three groups were separated, and the Hypo + Caf group was closer to the Con group. (Supplementary Figure S3B). 821 DEPs between the Hypo and Con groups and 687 DEPs between the Hypo + Caf and Hypo groups were detected (Supplementary Figure S3C; Supplementary Table S1). The volcano map of DEPs was shown, and the top 20 DEPs were labeled (Figure 5D; Supplementary Figure S3D). For these top 20 DEPs, we found that caffeine could markedly reverse the gene regulation induced by hypoxia. 60% of upregulated DEPs in hypoxia were decreased by caffeine, and 40% of downregulated DEPs in hypoxia were increased by caffeine (Figure 5D; Supplementary Figure S3D). The heatmap with hierarchical clustering demonstrated that the Hypo + Caf group was close to the Con group instead of the Hypo group (Figure 5A). Mfuzz clustering analysis revealed four clusters consisting of 98, 358, 402, and 224 quantified proteins, respectively (Figure 5B). Proteins in cluster 2 were downregulated in hypoxia but increased in Hypo + Caf group. In this cluster, oxidative phosphorylation was highly enriched (Figure 5C). Proteins in cluster 3 were upregulated in hypoxia but decreased in the Hypo + Caf group. The HIF-1a signaling pathway, ECM receptor interaction, and folate biosynthesis were enriched in cluster 3 (Figure 5C). From these clustering results, we found several pathways associated with energy metabolism and mitochondrial functions. The GO analysis of the upregulated DEPs between the Hypo + Caf and Hypo groups was significantly enriched in the ribosome (Supplementary Figure S3F), mitochondria (Figure 5E), and constituent of ribosome (Supplementary Figure S3G). Eight significant modules of DEPs were visualized via the Cytoscape MCODE app (Figure 5F), and the mitochondria-associated oxidative phosphorylation and mitophagy were marked. The suppressive oxidative phosphorylation manifests mitochondrial impairment (Brunetti et al., 2021), and mitophagy is one of the mechanisms to remove damaged mitochondria (Shan et al., 2019). We found that the upregulated KEGG pathway enriched the mitophagy pathway between the Hypo + Caf and Hypo groups (Supplementary Figure S3G). Most proteins in the mitophagy pathway were upregulated by caffeine could increase the expression of these proteins in hypoxia (Figure 5G). Therefore, we hypothesized that caffeine reduced mitochondrial damage in hypoxia by regulating mitophagy.
FIGURE 5
3.6 Caffeine mediated the mitochondrial quality control process
As damaged mitochondria need to be cleared, we next detected whether caffeine contributes to the clearing of low-quality mitochondria, which are known to be removed through multiple ways, such as cell apoptosis, autophagy, mitophagy and mitocytosis (Pickles et al., 2018; An et al., 2021; Jiao et al., 2021; Song et al., 2021). Mitophagy is a particular form of autophagy to clear the damaged mitochondria and maintains cell homeostasis (Li et al., 2018). We examined the immunofluorescence colocalization analysis of mitochondria and lysosomes. Mitochondria displayed a regular uniform network in the control group (Figure 6A, green fluorescence). While hypoxia resulted in mitochondria fragmentation and increased colocalization of mitochondria and lysosomes (red fluorescence), which reflected increased mitophagy (yellow fluorescence) (Figure 6A). The yellow fluorescence was intensive in the Hypo + Caf group (Figure 6A). The quantification of colocalization showed that caffeine enhanced the colocalization of Tom20 and LAMP1 (Figure 6B), which suggested that caffeine improved mitophagy in hypoxia. LC3 is a mammalian autophagosome with two isoforms, LC3-I and LC3-II. The conversion of the cytosolic-associated protein LC3-I to the membrane-bound LC3-II form is an important indicator of autophagosome activation. Therefore, the detection of LC3-II can be used to evaluate autophagosome formation (Bjorkoy et al., 2009). Western blot analysis showed that the expression level of LC3-II was significantly increased at the early stage of hypoxia treatment (24 h) and then gradually decreased (48 h). Caffeine treatment amplified the changes in LC3-II expression levels under hypoxic conditions. (Figures 6C,D). In addition, P62 was integrated into the formed autophagosome and degraded in autolysosomes, which was another common marker to study autophagic flux (Bjorkoy et al., 2009). The protein expression of p62 was decreased in hypoxia, suggesting enhanced autophagy. Compared with the Hypo group, caffeine further aggravated P62 degradation in hypoxia (Figure 6C; Figure 6E). Chloroquine (CQ) was an inhibitor of the fusion of autophagosomes and lysosomes, was used to further investigate the role of caffeine in the induction of mitophagy. We found that the enhanced autophagic flux induced by caffeine was inhibited by CQ (Figure 6C), which suggested that caffeine increased mitophagy by promoting autophagolysosome degradation.
FIGURE 6
Given the three classic pathways in mitophagy, we detected the expression of essential proteins in these pathways. BCL2/adenovirus E1B interacting protein 3 like (BNIP3L/Nix), a mitochondrial protein, plays a critical role in mitophagy (Fu et al., 2020). BNIP3L-mediated mitophagy is activated by HIF-1a in hypoxia (Lin Q. et al., 2021). BNIP3L protein showed low-level expression in normoxia and significantly increased in hypoxia. In comparison, we found that caffeine did not affect the expression of BNIP3L (Figures 6F,G). The second pathway is the PINK1/Parkin-dependent mitophagy pathway, which is the primary mechanism of mitochondrial membrane depolarization-induced mitophagy (Poole and Macleod, 2021). We found that hypoxia increased the expression of the total PINK1(t- PINK) and mitochondrial PINK1(m- PINK), and caffeine enlarged the degree of increase in hypoxia. Parkin is auto-inhibited and requires activation by PINK1, which phosphorylates Ser65 in the ubiquitin domain (Tan et al., 2022). The mitochondrial Parkin (m- Parkin) and phosphorylated Parkin (pParkin) were increased in hypoxia, and caffeine magnified this increased degree (Figures 6F,G), suggesting caffeine enhanced the PINK1/Parkin pathway in hypoxia. PARKIN phosphorylation is a signal to activate its E3 ligase activity, which leads to the ubiquitination of the VDAC, TOM20, COXII, MFNs, and multiple other mitochondrial membrane proteins to label the damaged mitochondria for mitophagy (Narendra et al., 2008). We found that damaged mitochondria, marked by parkin puncta (Saha et al., 2022), showed degradation of COXII protein under hypoxia and caffeine treatment (Supplementary Figure S4). The total FUNDC1 (t- FUNDC1) expression decreased in hypoxia, but caffeine did not affect its expression in hypoxia. The expression of mitochondrial FUNDC1 (m- FUNDC1) was slightly reduced in normoxia by caffeine but showed no difference in hypoxia (Figures 6F,G). Most changes in protein expression levels were consistent with quantitative proteomics results and proved the stability of the results (Figure 5G). These findings suggested that mitophagy was increased in hypoxia, which was further amplified by caffeine via the PINK1/Parkin pathway.
Excessive mitophagy decreased the number of mitochondria and impaired ATP production. But the number of mitochondria did not lessen in the Hypo + Caf group (Figures 4I–K). This indicated that there must be other mechanisms to regulate the number of mitochondria by caffeine. Previous studies reveal that fission underlies both proliferation and degradation of mitochondria (Kleele et al., 2021). Thus, we hypothesized whether caffeine also regulated mitochondrial fission in hypoxia to maintain the mitochondria quantity. To verify this conjecture, we detected the expression of dynamin-related protein 1 (DRP1), which is the signature protein of mitochondrial fission. The expression of the total DRP1 (t- DRP1) was decreased in hypoxia, while caffeine could significantly increase its expression. The expression of mitochondrial DRP1 (m- DRP1) was increased under hypoxic conditions, which was amplified by caffeine (Figures 6F,G). Peroxisome proliferator-activated receptor-γ coactivator-1-α (PGC-1α) is a master indicator of mitochondrial biogenesis (Li et al., 2017). The expression of PGC1α was increased in hypoxia, which was amplified by caffeine (Figures 6F,G). We next explored the mitophagy and mitochondrial fission markers in mice models. Consistently with the result in AT1 cells, the expression of PINK, pParkin (S65), LC3II, and DRP1 of lungs was also upregulated by caffeine, especially in hypoxia (Figures 6H,I). These results indicated that caffeine mediated mitochondrial quality control by activating mitophagy, mitochondrial biogenesis, and mitochondrial fission to mitigate the damage caused by hypoxia.
4 Discussion
High altitude pulmonary edema (HAPE) as one of the severe sub-type of high altitude illness is considered a life-threatening disease (Swenson and Bartsch, 2012; Wang Y. et al., 2022), but the effectiveness of current therapies was unsatisfactory (Luks et al., 2019; Luks and Hackett, 2022). Caffeine is a small molecule compound with biological activity, which can be used to treat respiratory distress syndrome (Ines et al., 2021; Elmowafi et al., 2022). HAPE has similar pathological changes to respiratory distress syndrome, but there is no report on whether caffeine plays a role in alleviating HAPE. In our study, we found that a low dose of caffeine could relieve HAPE through mediating the mitochondrial quality control to reduce oxidative stress in AT1 cells.
Through a series of experiments and bioinformatics analysis, we demonstrated that caffeine alleviates HAPE might by regulating the mitochondrial oxidative phosphorylation (OXPHOS) pathway. Previous studies show that caffeine could enhance OXPHOS to increase mitochondrial bioenergetics, promoting the necessary energy supply for brain recovery (Goncalves et al., 2020). We found that caffeine neutralized the ATP reduction and significantly increased the glycolytic capacity of AT1 cells in hypoxia. Mammalian cells normally require molecular oxygen to produce ATP as an energy source through the OXPHOS of mitochondria. However, under hypoxic conditions, the energy source is mainly provided by glycolysis (Wang D. et al., 2022). Tibetan chickens are well-adapted to hypoxia, showing decreased oxygen consumption rates and increased glycolysis to enable adaptation to hypoxia compared with dwarf-laying chickens (Tang et al., 2021). We found that caffeine significantly increased ATP production, especially GlycoATP production, under hypoxic conditions. The expressions of rate-limiting enzymes in glycolysis, such as PFKP and PKM1/2, were upregulated by caffeine. These results revealed that caffeine maintained an adequate energy supply by promoting glycolysis under hypoxic conditions in AT1 cells.
The accumulation of ROS caused by hypoxia leads to oxidative stress damage, disruption of mitochondrial structure and mitochondrial permeability transition (Bugger and Pfeil, 2020; Chowdhury et al., 2020; Sreedhar et al., 2020). We found that caffeine reduced the production of cytoplasmic ROS and mitochondrial ROS induced by hypoxia. MMP plays an important role in maintaining mitochondrial stability, and MMP depolarization induced by oxidative stress can induce cell apoptosis (Yang et al., 2019; Lin B. et al., 2021). We found decreased MMP and swelled mitochondria in hypoxia, but caffeine suppressed the MMP depolarization and recovered the typical morphological characteristics of mitochondria.
Caffeine alleviated hypoxic damage in HAPE by regulating mitochondrial quality control. To maintain the quality of mitochondria, cells must remove the damaged mitochondria in multiple ways, such as cell apoptosis, autophagy, mitophagy, and mitocytosis (Gao et al., 2021; Hyttinen et al., 2021; Jiao et al., 2021). What is the mechanism by which caffeine maintains the mitochondrial function under hypoxia? The label-free quantitative proteomics of AT1 cells indicated that caffeine promoted mitophagy. Mitophagy is a particular form of autophagy that clears the damaged mitochondria to maintain cell homeostasis (Li et al., 2018; Onishi et al., 2021). We explored the expression of proteins in three classic mitophagy pathways and found that caffeine enhanced the PINK1/Parkin-dependent mitophagy. But excessive mitophagy will cause insufficient numbers of mitochondria and decreased cellular resistance to injury due to energy shortage (Wu et al., 2020). We found no lessen in the number of mitochondria in the hypoxic and caffeine-treated groups. Hence, we detected the expression of signature proteins of mitochondrial fission (DRP1) and mitochondrial biogenesis (PGC-1α) to explore the effect of caffeine on mitochondrial fission and biogenesis. Indeed, caffeine upregulated the expression of DRP1and PGC1α, indicating the upregulation of mitochondrial fission and biogenesis. Collectively, we found that caffeine maintained mitochondrial quality control by regulating the PINK1/Parkin-dependent mitophagy, mitochondrial fission, and biogenesis.
5 Conclusion
In conclusion, we found that low-dose of caffeine could relieve pulmonary edema in hypobaric hypoxia in vivo. Caffeine attenuated hypoxia-induced mitochondrial damage by reducing oxidative stress and restoring mitochondrial morphology in vitro. Caffeine maintained the mitochondria quality control by enhancing the PINK1/Parkin-dependent mitophagy, promoting mitochondrial fission and biogenesis under hypoxic conditions. Furthermore, our results suggest that caffeine alleviated HAPE via regulating mitochondrial dynamics in AT1 cells, but further research is needed to determine whether a low dose of caffeine can increase mitochondrial turnover in other types of alveoli cells.
Statements
Data availability statement
The raw proteomic data analyzed in this study are available at iProX with the corresponding dataset identifier PXD034002 (https://www.iprox.cn/page/project.html?id=IPX0004468000).
Ethics statement
The animal study was reviewed and approved by The Animal Ethics Committee of the Chinese PLA General Hospital (SQ2020030) approved all experimental procedures involving animals.
Author contributions
KH and XZ conceived and designed the experiments. LT, YY and QJ performed the in vivo experiments. LT, SC, and HC performed the in vitro experiments. LT, WS and YH performed the collation and analysis of proteomics data. LT drafted the manuscript. ZJ performed supervision of the bioinformatic section, data interpretation and manuscript edit. All authors critically revised the manuscript for important intellectual content. All authors approved the final version of the manuscript.
Funding
This work was supported by the Science and Technology Innovation Special Zone (grant number 19-163-12-ZD-037-003-02) and the National Natural Sciences Foundation of China (grant number 82001994 and 31701155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2023.1155414/full#supplementary-material
Abbreviations
HAPE, High-altitude pulmonary edema; AHAI, Acute high altitude illness; HIF-1α, hypoxia-inducible factor-1α; VEGF, vascular endothelial growth factor; ROS, reactive oxygen species; RDS, respiratory distress syndrome; UPLC, ultra-performance liquid chromatography; LFQ, label-free quantitation; DEPs, differentially expressed proteins; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; AT1, Type Ⅰ alveolar epithelial; FBS, Fetal bovine serum; OCR, oxygen consumption rate; ECAR, extracellular acidification rate; 2-DG, 2-deoxy-D-glucose; MMP, mitochondrial membrane potential; PCA, Principal component analysis; DRP1, dynamin related protein 1; PGC-1α, peroxisome proliferator-activated receptor-γ coactivator-1-α.
References
1
AnH.ZhouB.JiX. (2021). Mitochondrial quality control in acute ischemic stroke. J. Cereb. Blood Flow. Metab.41 (12), 3157–3170. 10.1177/0271678X211046992
2
AshburnerM.BallC. A.BlakeJ. A.BotsteinD.ButlerH.CherryJ. M.et al (2000). Gene ontology: Tool for the unification of biology. The gene Ontology consortium. Nat. Genet.25 (1), 25–29. 10.1038/75556
3
BalogluE.NonnenmacherG.SeleninovaA.BergL.VelineniK.Ermis-KayaE.et al (2020). The role of hypoxia-induced modulation of alveolar epithelial Na(+)- transport in hypoxemia at high altitude. Pulm. Circ.10, 50–58. 10.1177/2045894020936662
4
BarreaL.VetraniC.CaprioM.El GhochM.Frias-ToralE.MehtaR. J.et al (2021). Nutritional management of type 2 diabetes in subjects with obesity: An international guideline for clinical practice. Crit. Rev. Food Sci. Nutr.2021, 1–13. 10.1080/10408398.2021.1980766
5
BjorkoyG.LamarkT.PankivS.OvervatnA.BrechA.JohansenT. (2009). Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol.452, 181–197. 10.1016/S0076-6879(08)03612-4
6
BrunettiD.DykstraW.LeS.ZinkA.PrigioneA. (2021). Mitochondria in neurogenesis: Implications for mitochondrial diseases. Stem Cells39 (10), 1289–1297. 10.1002/stem.3425
7
BuggerH.PfeilK. (2020). Mitochondrial ROS in myocardial ischemia reperfusion and remodeling. Biochim. Biophys. Acta Mol. Basis Dis.1866 (7), 165768. 10.1016/j.bbadis.2020.165768
8
ChowdhuryA. R.ZielonkaJ.KalyanaramanB.HartleyR. C.MurphyM. P.AvadhaniN. G. (2020). Mitochondria-targeted paraquat and metformin mediate ROS production to induce multiple pathways of retrograde signaling: A dose-dependent phenomenon. Redox Biol.36, 101606. 10.1016/j.redox.2020.101606
9
DonchevaN. T.MorrisJ. H.GorodkinJ.JensenL. J. (2019). Cytoscape StringApp: Network analysis and visualization of proteomics data. J. Proteome Res.18 (2), 623–632. 10.1021/acs.jproteome.8b00702
10
EatonD. C.HelmsM. N.KovalM.BaoH. F.JainL. (2009). The contribution of epithelial sodium channels to alveolar function in health and disease. Annu. Rev. Physiology71 (1), 403–423. 10.1146/annurev.physiol.010908.163250
11
ElmowafiM.MohsenN.NourI.et al (2022). Prophylactic versus therapeutic caffeine for apnea of prematurity: A randomized controlled trial. J. Matern. Fetal Neonatal Med.35 (25), 6053–6061. 10.1080/14767058.2021.1904873
12
FormanH. J.AugustoO.Brigelius-FloheR.DenneryP. A.KalyanaramanB.IschiropoulosH.et al (2015). Even free radicals should follow some rules: A guide to free radical research terminology and methodology. Free Radic. Biol. Med.78, 233–235. 10.1016/j.freeradbiomed.2014.10.504
13
FuZ. J.WangZ. Y.XuL.ChenX. H.LiX. X.LiaoW. T.et al (2020). HIF-1α-BNIP3-mediated mitophagy in tubular cells protects against renal ischemia/reperfusion injury. Redox Biol.36, 101671. 10.1016/j.redox.2020.101671
14
GaoH.LiuZ.XuW.WangQ.ZhangC.DingY.et al (2021). Pterostilbene promotes mitochondrial apoptosis and inhibits proliferation in glioma cells. Sci. Rep.11 (1), 6381. 10.1038/s41598-021-85908-w
15
GiussaniD. A.NiuY.HerreraE. A.RichterH. G.CammE. J.ThakorA. S.et al (2014). Heart disease link to fetal hypoxia and oxidative stress. Adv. Exp. Med. Biol.814, 77–87. 10.1007/978-1-4939-1031-1_7
16
GoldmanA. R.BeerL. A.TangH. Y.HembachP.Zayas-BazanD.SpeicherD. W. (2019). Proteome analysis using gel-LC-MS/MS. Curr. Protoc. Protein Sci.96 (1), e93. 10.1002/cpps.93
17
GoncalvesD. F.TassiC. C.AmaralG. P.StefanelloS. T.Dalla CorteC. L.SoaresF. A.et al (2020). Effects of caffeine on brain antioxidant status and mitochondrial respiration in acetaminophen-intoxicated mice. Toxicol. Res. (Camb)9 (5), 726–734. 10.1093/toxres/tfaa075
18
HackettP. H.RennieD.LevineH. D. (1976). The incidence, importance, and prophylaxis of acute mountain sickness. Lancet2 (7996), 1149–1155. 10.1016/s0140-6736(76)91677-9
19
HyttinenJ.BlasiakJ.TaviP.KaarnirantaK. (2021). Therapeutic potential of PGC-1α in age-related macular degeneration (AMD) - the involvement of mitochondrial quality control, autophagy, and antioxidant response. Expert Opin. Ther. Targets25 (9), 773–785. 10.1080/14728222.2021.1991913
20
IkramM.ParkT. J.AliT.KimM. O. (2020). Antioxidant and neuroprotective effects of caffeine against alzheimer's and Parkinson's disease: Insight into the role of nrf-2 and A2AR signaling. Antioxidants (Basel)9 (9), 902. 10.3390/antiox9090902
21
InesF.HutsonS.CoughlinK.HopperA.BanerjiA.UyC.et al (2021). Multicentre, randomised trial of preterm infants receiving caffeine and less invasive surfactant administration compared with caffeine and early continuous positive airway pressure (CaLI trial): Study protocol. BMJ Open11 (1), e038343. 10.1136/bmjopen-2020-038343
22
JiaoH.JiangD.HuX.DuW.JiL.YangY.et al (2021). Mitocytosis, a migrasome-mediated mitochondrial quality-control process. Cell.184 (11), 2896–2910 e13. 10.1016/j.cell.2021.04.027
23
KalyanaramanB.Darley-UsmarV.DaviesK. J. A.DenneryP. A.FormanH. J.GrishamM. B.et al (2012). Measuring reactive oxygen and nitrogen species with fluorescent probes: Challenges and limitations. Free Radic. Biol. Med.52 (1), 1–6. 10.1016/j.freeradbiomed.2011.09.030
24
KanehisaM.FurumichiM.SatoY.Ishiguro-WatanabeM.TanabeM. (2021). Kegg: Integrating viruses and cellular organisms. Nucleic Acids Res.49 (D1), D545–D551. 10.1093/nar/gkaa970
25
KhodaeeM.GrotheH. L.SeyfertJ. H.VanBaakK. (2016). Athletes at high altitude. Sports Health8 (2), 126–132. 10.1177/1941738116630948
26
KleeleT.ReyT.WinterJ.ZaganelliS.MahecicD.Perreten LambertH.et al (2021). Distinct fission signatures predict mitochondrial degradation or biogenesis. Nature593 (7859), 435–439. 10.1038/s41586-021-03510-6
27
LabuschagneC. F.CheungE. C.BlagihJ.DomartM. C.VousdenK. H. (2019). Cell clustering promotes a metabolic switch that supports metastatic colonization. Cell. Metab.30 (4), 720–734 e5. 10.1016/j.cmet.2019.07.014
28
LiH. L.ZaghloulN.AhmedI.OmelchenkoA.FiresteinB. L.HuangH.et al (2019). Caffeine inhibits hypoxia-induced nuclear accumulation in HIF-1α and promotes neonatal neuronal survival. Exp. Neurol.317, 66–77. 10.1016/j.expneurol.2019.01.014
29
LiP. A.HouX.HaoS. (2017). Mitochondrial biogenesis in neurodegeneration. J. Neurosci. Res.95 (10), 2025–2029. 10.1002/jnr.24042
30
LiW.LongL.YangX.TongZ.SouthwoodM.KingR.et al (2020). Circulating BMP9 protects the pulmonary endothelium during inflammation-induced lung injury in mice. Am. J. Respir. Crit. Care Med.203 (11), 1419–1430. 10.1164/rccm.202005-1761OC
31
LiY. F.OuyangS. H.TuL. F.WangX.YuanW. L.WangG. E.et al (2018). Caffeine protects skin from oxidative stress-induced senescence through the activation of autophagy. Theranostics8 (20), 5713–5730. 10.7150/thno.28778
32
LinB.LiuY.ZhangX.FanL.ShuY.WangJ. (2021). Membrane-activated fluorescent probe for high-fidelity imaging of mitochondrial membrane potential. ACS Sens.6 (11), 4009–4018. 10.1021/acssensors.1c01390
33
LinQ.LiS.JiangN.JinH.ShaoX.ZhuX.et al (2021). Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy. Autophagy17 (10), 2975–2990. 10.1080/15548627.2020.1848971
34
LuksA. M.AuerbachP. S.FreerL.GrissomC. K.KeyesL. E.McIntoshS. E.et al (2019). Wilderness medical society clinical practice guidelines for the prevention and treatment of acute altitude illness: 2019 update. Wilderness Environ. Med.30 (4S), S3–S18. 10.1016/j.wem.2019.04.006
35
LuksA. M.HackettP. H. (2022). Medical conditions and high-altitude travel. N. Engl. J. Med.386 (4), 364–373. 10.1056/NEJMra2104829
36
MaJ.ChenT.WuS.YangC.BaiM.ShuK.et al (2019). iProX: an integrated proteome resource. Nucleic Acids Res.47 (D1), D1211–D1217. 10.1093/nar/gky869
37
MarteL.BoronatS.Garcia-SantamarinaS.AyteJ.KitamuraK.HidalgoE. (2020). Identification of ubiquitin-proteasome system components affecting the degradation of the transcription factor Pap1. Redox Biol.28, 101305. 10.1016/j.redox.2019.101305
38
McGarryT.BinieckaM.VealeD. J.FearonU. (2018). Hypoxia, oxidative stress and inflammation. Free Radic. Biol. Med.125, 15–24. 10.1016/j.freeradbiomed.2018.03.042
39
McGuireS. (2014). Caffeine in food and dietary supplements: Examining safety-workshop summary. Washington, DC: The National Academies Press.
40
McKeownS. R. (2014). Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. Br. J. Radiol.87 (1035), 20130676. 10.1259/bjr.20130676
41
MillarF. R.SummersC.GriffithsM. J.ToshnerM. R.ProudfootA. G. (2016). The pulmonary endothelium in acute respiratory distress syndrome: Insights and therapeutic opportunities. Thorax71 (5), 462–473. 10.1136/thoraxjnl-2015-207461
42
MinH.YounE.KimJ.SonS. Y.LeeC. H.ShimY. H. (2020). Effects of phosphoethanolamine supplementation on mitochondrial activity and lipogenesis in a caffeine ingestion Caenorhabditis elegans model. Nutrients12 (11), 3348. 10.3390/nu12113348
43
NairA. B.JacobS. (2016). A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm.7 (2), 27–31. 10.4103/0976-0105.177703
44
NarendraD.TanakaA.SuenD. F.YouleR. J. (2008). Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell. Biol.183 (5), 795–803. 10.1083/jcb.200809125
45
NiQ.ShaoY.WangY. Z.JingY. H.ZhangY. C. (2014). Impact of high altitude on the hepatic fatty acid oxidation and synthesis in rats. Biochem. Biophys. Res. Commun.446 (2), 574–579. 10.1016/j.bbrc.2014.03.001
46
NilnumkhumA.KanlayaR.YoodeeS.ThongboonkerdV. (2019). Caffeine inhibits hypoxia-induced renal fibroblast activation by antioxidant mechanism. Cell. Adh Migr.13 (1), 260–272. 10.1080/19336918.2019.1638691
47
OnishiM.YamanoK.SatoM.MatsudaN.OkamotoK. (2021). Molecular mechanisms and physiological functions of mitophagy. EMBO J.40 (3), e104705. 10.15252/embj.2020104705
48
PicklesS.VigieP.YouleR. J. (2018). Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr. Biol.28 (4), R170–R185. 10.1016/j.cub.2018.01.004
49
PooleL. P.MacleodK. F. (2021). Mitophagy in tumorigenesis and metastasis. Cell. Mol. Life Sci.78 (8), 3817–3851. 10.1007/s00018-021-03774-1
50
RenJ.DingX.GreerJ. J. (2015). Ampakines enhance weak endogenous respiratory drive and alleviate apnea in perinatal rats. Am. J. Respir. Crit. Care Med.191 (6), 704–710. 10.1164/rccm.201410-1898OC
51
SahaB.SalemiM.WilliamsG. L.OhS.PaffettM. L.PhinneyB.et al (2022). Interactomic analysis reveals a homeostatic role for the HIV restriction factor TRIM5α in mitophagy. Cell. Rep.39 (6), 110797. 10.1016/j.celrep.2022.110797
52
SakamuruS.Attene-RamosM. S.XiaM. (2016). Mitochondrial membrane potential assay. Methods Mol. Biol.1473, 17–22. 10.1007/978-1-4939-6346-1_2
53
ShanS.ShenZ.ZhangC.KouR.XieK.SongF. (2019). Mitophagy protects against acetaminophen-induced acute liver injury in mice through inhibiting NLRP3 inflammasome activation. Biochem. Pharmacol.169, 113643. 10.1016/j.bcp.2019.113643
54
Sharma KandelR.MishraR.GautamJ.AlarefA.HassanA.JahanN. (2020). Patchy vasoconstriction versus inflammation: A debate in the pathogenesis of high altitude pulmonary edema. Cureus12 (9), e10371. 10.7759/cureus.10371
55
SongJ.HerrmannJ. M.BeckerT. (2021). Quality control of the mitochondrial proteome. Nat. Rev. Mol. Cell. Biol.22 (1), 54–70. 10.1038/s41580-020-00300-2
56
SreedharA.Aguilera-AguirreL.SinghK. K. (2020). Mitochondria in skin health, aging, and disease. Cell. Death Dis.11 (6), 444. 10.1038/s41419-020-2649-z
57
SwensonE. R.BartschP. (2012). High-altitude pulmonary edema. Compr. Physiol.2 (4), 2753–2773. 10.1002/cphy.c100029
58
SwensonE. R.BartschP. (2021). The search for a model of high-altitude pulmonary oedema must continue. Acta Physiol. (Oxf)231 (1), e13485. 10.1111/apha.13485
59
SzklarczykD.GableA. L.NastouK. C.LyonD.KirschR.PyysaloS.et al (2021). The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res.49 (D1), D605–D612. 10.1093/nar/gkaa1074
60
SzlapinskiS. K.CharretteA.GuthrieN.HilmasC. J. (2023). Paraxanthine safety and comparison to caffeine. Front. Toxicol.5, 1117729. 10.3389/ftox.2023.1117729
61
TanH. W. S.LuG.DongH.ChoY. L.NataliaA.WangL.et al (2022). A degradative to secretory autophagy switch mediates mitochondria clearance in the absence of the mATG8-conjugation machinery. Nat. Commun.13 (1), 3720. 10.1038/s41467-022-31213-7
62
TangQ.DingC.XuQ.BaiY.XuQ.WangK.et al (2021). Mitochondrial fusion potentially regulates a metabolic change in Tibetan chicken embryonic brain during hypoxia. Front. Cell. Dev. Biol.9, 585166. 10.3389/fcell.2021.585166
63
TianL.JiaZ.XuZ.ShiJ.ZhaoX.HeK. (2021). Transcriptional landscape in rat intestines under hypobaric hypoxia. PeerJ9, e11823. 10.7717/peerj.11823
64
TuletaI.StockigtF.JuergensU. R.PizarroC.SchrickelJ. W.KristiansenG.et al (2016). Intermittent hypoxia contributes to the lung damage by increased oxidative stress, inflammation, and disbalance in protease/antiprotease system. Lung194 (6), 1015–1020. 10.1007/s00408-016-9946-4
65
VelazquezA. M.RoglansN.BentanachsR.GeneM.Sala-VilaA.LazaroI.et al (2020). Effects of a low dose of caffeine alone or as part of a green coffee extract, in a rat dietary model of lean non-alcoholic fatty liver disease without inflammation. Nutrients12 (11), 3240. 10.3390/nu12113240
66
WangD.LiuF.YangW.SunY.WangX.SuiX.et al (2022). Meldonium ameliorates hypoxia-induced lung injury and oxidative stress by regulating platelet-type phosphofructokinase-mediated glycolysis. Front. Pharmacol.13, 863451. 10.3389/fphar.2022.863451
67
WangY.HuangX.PengF.HanH.GuY.LiuX.et al (2022). Association of variants m.T16172C and m.T16519C in whole mtDNA sequences with high altitude pulmonary edema in Han Chinese lowlanders. BMC Pulm. Med.22 (1), 72. 10.1186/s12890-021-01791-1
68
WuJ.YangY.GaoY.WangZ.MaJ. (2020). Melatonin attenuates anoxia/reoxygenation injury by inhibiting excessive mitophagy through the MT2/SIRT3/FoxO3a signaling pathway in H9c2 cells. Drug Des. Devel Ther.14, 2047–2060. 10.2147/DDDT.S248628
69
YanamandraU.SharmaM.KatochD.YanamandraS.BhattacharS. A.GuptaA.et al (2019). High-altitude pulmonary oedema: Newer treatment modalities for an age-old problem. Indian J. Med. Res.149 (6), 778–782. 10.4103/ijmr.IJMR_1981_17
70
YangF.PeiR.ZhangZ.LiaoJ.YuW.QiaoN.et al (2019). Copper induces oxidative stress and apoptosis through mitochondria-mediated pathway in chicken hepatocytes. Toxicol Vitro54, 310–316. 10.1016/j.tiv.2018.10.017
Summary
Keywords
caffeine, high altitude pulmonary edema (HAPE), mitochondrial, mitochondrial quality control, proteomics
Citation
Tian L, Jia Z, Yan Y, Jia Q, Shi W, Cui S, Chen H, Han Y, Zhao X and He K (2023) Low-dose of caffeine alleviates high altitude pulmonary edema via regulating mitochondrial quality control process in AT1 cells. Front. Pharmacol. 14:1155414. doi: 10.3389/fphar.2023.1155414
Received
31 January 2023
Accepted
23 March 2023
Published
04 April 2023
Volume
14 - 2023
Edited by
Na Wang, Tongji University, China
Reviewed by
Bhaskar Saha, University of New Mexico, United States
Qiuhua Yang, Augusta University, United States
Changwen Deng, Tongji University, China
Updates
Copyright
© 2023 Tian, Jia, Yan, Jia, Shi, Cui, Chen, Han, Zhao and He.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zhilong Jia, jiazhilong@plagh.org; Xiaojing Zhao, xjingzhao@126.com; Kunlun He, kunlunhe@plagh.org
†These authors have contributed equally to this work
This article was submitted to Respiratory Pharmacology, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.